Skip to main content
SLEEMON HEALTHY SLEEP TECHNOLOGY CO., LTD. logo

SLEEMON HEALTHY SLEEP TECHNOLOGY CO., LTD. — Investor Relations & Filings

Ticker · 603008 ISIN · CNE100001JQ0 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 1,680 across all filing types
Latest filing 2026-05-18 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 603008

About SLEEMON HEALTHY SLEEP TECHNOLOGY CO., LTD.

http://www.sleemon.com/

SLEEMON HEALTHY SLEEP TECHNOLOGY CO., LTD. focuses on the research, development, and production of comprehensive sleep solutions. The company’s primary product range includes spring mattresses, latex mattresses, smart sleep systems, and upholstered furniture. By integrating ergonomic design with advanced material science, the firm develops products aimed at enhancing sleep health and spinal support. Its operations encompass the entire value chain, from design and manufacturing to global distribution. Sleemon serves a diverse clientele, including individual consumers and large-scale hospitality providers, offering both standardized and bespoke bedding products. The company distinguishes itself through its commitment to technological innovation in sleep science, utilizing automated manufacturing and smart monitoring features to provide data-driven sleep improvements.

Recent filings

Filing Released Lang Actions
喜临门健康睡眠科技股份公司关于公司股票交易异常波动的公告
Regulatory Filings Classification · 85% confidence The document is an announcement concerning the company’s abnormal stock trading fluctuation and related risk disclosures under Shanghai Stock Exchange rules. It does not contain financial statements (so it is not an IR or 10-K), nor is it an earnings release, management change, or dividend notice. It is a mandatory regulatory announcement of unusual trading and associated risks, falling under general regulatory filings.
2026-05-18 Chinese
喜临门健康睡眠科技股份公司关于公司股票交易异常波动的公告
Regulatory Filings Classification · 80% confidence The document is an official exchange announcement (“公告”) regarding abnormal stock trading fluctuations, risk disclosures, and regulatory inquiries under Shanghai Stock Exchange rules. It is not a financial report itself (e.g., interim report) nor a notice of a report release, nor a specific event like dividend or board change. It falls into the general category of regulatory announcements that do not fit other specific filing types. Therefore, it is classified as a Regulatory Filing (RNS).
2026-05-13 Chinese
喜临门健康睡眠科技股份公司关于控股股东、实际控制人及其一致行动人股份被轮候冻结的公告
Regulatory Filings Classification · 85% confidence The document is a formal corporate disclosure announcing the judicial freezing (“轮候冻结”) of shares held by the company’s controlling shareholder, actual controller and related concert parties. It describes shareholding amounts, freeze dates, related court actions and litigation details. This is not a financial report (10-K, IR), earnings release or proxy statement; it is not a share repurchase or new issuance. It is a mandatory regulatory announcement of a legal/compliance nature that does not fit more specific categories, so it falls under the general Regulatory Filings category (RNS).
2026-05-12 Chinese
喜临门健康睡眠科技股份公司关于上海证券交易所对公司银行账户资金划转及冻结相关事项的监管工作函的回复公告
Regulatory Filings Classification · 87% confidence The document is a formal public reply by the company to regulatory letters from the Shanghai Stock Exchange regarding bank account fund transfers, freezes, and related internal control issues. It does not itself present financial results (so not ER or IR), management discussion (MDA), or an annual/interim report. It’s not a board change (MANG), a proxy statement (PSI), or a dividend notice (DIV). Rather it is a regulatory disclosure of material events and responses to exchange inquiries, fitting the catch-all “Regulatory Filings” category (RNS).
2026-04-24 Chinese
喜临门健康睡眠科技股份公司2025年年度报告
Annual Report Classification · 100% confidence The document is titled '2025年度报告' (2025 Annual Report) and contains standard sections for an annual report, including 'Management Discussion and Analysis', 'Financial Reports', 'Corporate Governance', and 'Major Financial Indicators'. It is a comprehensive document (203 pages total) detailing the company's performance, financial statements, and business operations for the fiscal year 2025. It is not a short announcement or a summary, but the full report itself. FY 2025
2026-04-24 Chinese
喜临门健康睡眠科技股份公司关于2026年度日常关联交易预计的公告
Regulatory Filings Classification · 85% confidence The document is an official announcement by a Chinese listed company (SSE code 603008) regarding its projected ordinary related‐party transactions for the 2026 fiscal year. It details board approval procedures, transaction categories, counterparties, amounts, pricing policy, and impact on the company. This is a regulatory disclosure of related‐party transactions and does not fit any more specific category such as earnings release, capital update, share issue, or financial report. Therefore, it falls into the fallback “Regulatory Filings” category.
2026-04-24 Chinese

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.